MOLINA HEALTHCARE INC (MOH) Stock Analyst Earnings Estimates
NYSE:MOH - New York Stock Exchange, Inc. - US60855R1005 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.974B 15.13% | 34.072B 6.56% | 40.65B 19.31% | 44.804B 10.22% | 47.973B 7.07% | 50.982B 6.27% | 55.842B 9.53% | 58.252B 4.32% | |
| EBITDA YoY % growth | 1.615B 29.61% | 1.785B 10.53% | 1.894B 6.11% | 2.092B 10.45% | 2.325B 11.14% | 2.484B 6.84% | N/A | N/A | |
| EBIT YoY % growth | 1.439B 29.06% | 1.614B 12.16% | 1.708B 5.82% | 1.867B 9.31% | 2.116B 13.34% | 2.375B 12.24% | 2.67B 12.42% | 2.862B 7.19% | |
| Operating Margin | 4.50% | 4.74% | 4.20% | 4.17% | 4.41% | 4.66% | 4.78% | 4.91% | |
| EPS YoY % growth | 17.91 32.18% | 20.89 16.64% | 22.65 8.43% | 23.85 5.28% | 27.44 15.08% | 31.27 13.94% | 39.97 27.82% | 43.77 9.53% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.70 -21.72% | 4.11 -18.64% | 6.85 12.72% | 7.40 35.09% | 7.28 54.67% | 6.85 66.74% | 7.93 15.76% | 8.06 8.94% | 8.12 11.59% | 7.45 8.73% |
| Revenue Q2Q % growth | 11.028B 6.65% | 11.09B 5.63% | 12.117B 8.70% | 11.663B 2.07% | 11.995B 8.77% | 12.299B 10.90% | 11.967B -1.24% | 12.041B 3.24% | 12.665B 5.59% | 12.728B 3.49% |
| EBITDA Q2Q % growth | 411.02M -32.06% | 387.08M -31.37% | 556.32M 15.18% | 605.57M 26.16% | 588.85M 43.27% | 560.07M 44.69% | 601.18M 8.06% | 601.47M -0.68% | 610.94M 3.75% | 586.19M 4.66% |
| EBIT Q2Q % growth | 374.81M -19.74% | 331.94M -12.19% | 484.23M 11.32% | 566.79M 51.55% | 549.15M 46.51% | 519.71M 56.57% | 573.66M 18.47% | 574.97M 1.44% | 581.81M 5.95% | 556.92M 7.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.48 -6.48% | 5.85 | -0.37 | -6.27% |
| Q1 2025 Q2Q % growth | 6.08 6.11% | 6.02 | 0.06 | 1.06% |
| Q4 2024 Q2Q % growth | 5.05 15.30% | 5.78 | -0.73 | -12.62% |
| Q3 2024 Q2Q % growth | 6.01 19.01% | 5.86 | 0.15 | 2.51% |
| Q2 2024 Q2Q % growth | 5.86 3.72% | 5.56 | 0.30 | 5.45% |
| Q1 2024 Q2Q % growth | 5.73 -1.38% | 5.64 | 0.09 | 1.51% |
| Q4 2023 Q2Q % growth | 4.38 6.83% | 4.39 | -0.01 | -0.33% |
| Q3 2023 Q2Q % growth | 5.05 15.83% | 4.93 | 0.12 | 2.44% |
| Q2 2023 Q2Q % growth | 5.65 24.18% | 5.15 | 0.50 | 9.76% |
| Q1 2023 Q2Q % growth | 5.81 18.57% | 5.17 | 0.64 | 12.27% |
| Q4 2022 Q2Q % growth | 4.10 42.36% | 4.06 | 0.04 | 1.07% |
| Q3 2022 Q2Q % growth | 4.36 54.06% | 4.25 | 0.11 | 2.53% |
| Q2 2022 Q2Q % growth | 4.55 33.82% | 4.34 | 0.21 | 4.90% |
| Q1 2022 Q2Q % growth | 4.90 10.36% | 4.71 | 0.19 | 4.14% |
| Q4 2021 Q2Q % growth | 2.88 664.71% | 2.78 | 0.10 | 3.75% |
| Q3 2021 Q2Q % growth | 2.83 -15.77% | 2.82 | 0.01 | 0.37% |
| Q2 2021 Q2Q % growth | 3.40 -29.02% | 3.41 | -0.01 | -0.30% |
| Q1 2021 Q2Q % growth | 4.44 47.02% | 3.72 | 0.72 | 19.46% |
| Q4 2020 Q2Q % growth | -0.51 -118.68% | 0.90 | -1.41 | -156.91% |
| Q3 2020 Q2Q % growth | 3.36 20.00% | 2.19 | 1.17 | 53.16% |
| Q2 2020 Q2Q % growth | 4.79 54.02% | 4.77 | 0.02 | 0.33% |
| Q1 2020 Q2Q % growth | 3.02 -0.66% | 2.97 | 0.05 | 1.53% |
| Q4 2019 Q2Q % growth | 2.73 | 2.67 | 0.06 | 2.13% |
| Q3 2019 Q2Q % growth | 2.80 | 2.75 | 0.05 | 1.85% |
| Q2 2019 Q2Q % growth | 3.11 | 2.68 | 0.43 | 15.93% |
| Q1 2019 Q2Q % growth | 3.04 | 2.47 | 0.57 | 23.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 11.427B 15.66% | 11.063B | 364M | 3.29% |
| Q1 2025 Q2Q % growth | 11.147B 12.24% | 10.914B | 233M | 2.13% |
| Q4 2024 Q2Q % growth | 10.499B 16.04% | 10.427B | 72M | 0.69% |
| Q3 2024 Q2Q % growth | 10.34B 20.96% | 10.01B | 330M | 3.30% |
| Q2 2024 Q2Q % growth | 9.88B 18.65% | 9.844B | 36M | 0.37% |
| Q1 2024 Q2Q % growth | 9.931B 21.87% | 9.535B | 396M | 4.15% |
| Q4 2023 Q2Q % growth | 9.048B 10.03% | 8.452B | 596M | 7.05% |
| Q3 2023 Q2Q % growth | 8.548B 7.83% | 8.326B | 222M | 2.67% |
| Q2 2023 Q2Q % growth | 8.327B 3.39% | 8.4B | -73M | -0.87% |
| Q1 2023 Q2Q % growth | 8.149B 4.88% | 8.413B | -264M | -3.14% |
| Q4 2022 Q2Q % growth | 8.223B 10.99% | 7.95B | 273M | 3.43% |
| Q3 2022 Q2Q % growth | 7.927B 12.60% | 7.878B | 49M | 0.62% |
| Q2 2022 Q2Q % growth | 8.054B 18.44% | 7.765B | 289M | 3.72% |
| Q1 2022 Q2Q % growth | 7.77B 19.14% | 7.596B | 174M | 2.29% |
| Q4 2021 Q2Q % growth | 7.409B 41.53% | 7.262B | 147M | 2.02% |
| Q3 2021 Q2Q % growth | 7.04B 40.21% | 6.855B | 185M | 2.70% |
| Q2 2021 Q2Q % growth | 6.8B 47.25% | 6.443B | 357M | 5.54% |
| Q1 2021 Q2Q % growth | 6.522B 43.37% | 6.12B | 402M | 6.57% |
| Q4 2020 Q2Q % growth | 5.235B 22.48% | 5.351B | -116M | -2.17% |
| Q3 2020 Q2Q % growth | 5.021B 18.34% | 4.904B | 117M | 2.39% |
| Q2 2020 Q2Q % growth | 4.618B 10.14% | 4.767B | -149M | -3.13% |
| Q1 2020 Q2Q % growth | 4.549B 10.44% | 4.513B | 36M | 0.80% |
| Q4 2019 Q2Q % growth | 4.274B | 4.325B | -51M | -1.18% |
| Q3 2019 Q2Q % growth | 4.243B | 4.185B | 58M | 1.39% |
| Q2 2019 Q2Q % growth | 4.193B | 4.126B | 67M | 1.62% |
| Q1 2019 Q2Q % growth | 4.119B | 4.111B | 8M | 0.19% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -25.49% | -25.74% | -3.54% | -3.57% |
| Revenue | -0.51% | -0.74% | 0.38% | 1.15% |